Makes low-cost copies of popular medicines, plus its own drugs.
No change
Greenlight owns 2.9 million shares of Teva, worth about $98 million. That’s $3 of every $100 they have in stocks. They didn’t really buy or sell any between April and June.
Mar 31
2,910,729
Jun 30
2,886,059
The numbers
Shares they own
2,886,059
Change since Mar 31
−24,670
tiny change (0.8%)
Shares on Mar 31
2,910,729
Value on Jun 30, 2026
$97,779,679
about $98 million
Share of their money
2.5%
$3 of every $100 · 12th of 46
Price per share on Jun 30
$33.88
Kind
Shares
More about Teva ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.